Omega Therapeutics, Inc. (OMGA)

USD 0.83

(-3.2%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 3.09 Million 2.07 Million 144 Thousand - -
Cost of Revenue 65.86 Million 5.19 Million 1.38 Million 1.14 Million 794 Thousand
Gross Profit -62.77 Million -3.11 Million -1.24 Million -1.14 Million -794 Thousand
Operating Expenses 103.35 Million 104.83 Million 66.17 Million 28.64 Million 17.33 Million
Selling, General and Administrative Expenses 26.18 Million 21.82 Million 16.6 Million 6.23 Million 4.22 Million
Research and Development Expenses 77.16 Million 79.99 Million 47.86 Million 21.06 Million 11.93 Million
Other Expenses - 3.02 Million 1.7 Million 1.34 Million 1.18 Million
Cost and Expenses 103.35 Million 104.83 Million 66.17 Million 28.64 Million 17.33 Million
Operating Income -100.26 Million -102.76 Million -66.03 Million -28.64 Million -17.33 Million
Interest Expense - 222 Thousand 910 Thousand 777 Thousand 595 Thousand
Income Tax Expense - -65 Thousand 882 Thousand 752 Thousand 584 Thousand
Earnings before Tax -97.42 Million -102.7 Million -68.28 Million -29.44 Million -17.94 Million
Net Income -97.42 Million -102.63 Million -69.16 Million -30.19 Million -18.52 Million
Earnings Per Share Basic -1.80 -2.14 -1.45 -0.63 -0.39
Earnings Per Share Diluted -1.80 -2.14 -1.45 -0.63 -0.39
Weighted Average Shares Outstanding 54.01 Million 47.88 Million 47.79 Million 47.83 Million 47.83 Million
Weighted Average Shares Outstanding (Diluted) 54.01 Million 47.88 Million 47.79 Million 47.83 Million 47.83 Million
Gross Margin -20.29 -1.50 -8.63 - -
EBIT Margin -30.22 -49.57 -449.12 - -
Profit Margin -31.49 -49.51 -480.29 - -
EBITDA -93.49 Million -97.57 Million -64.64 Million -27.49 Million -16.54 Million
Earnings Before Tax Margin -32.40 -49.57 -458.56 - -

Income Statement Charts